The Novartis Institutes for BioMedical Research is seeking to advance science through the NIBR Global Scholars Program (NGSP). NGSP matches innovative thinkers from select academic institutions with NIBR scientists to explore new and exciting research directions to discover and develop transformative medicines.

Program Highlights

Exclusive opportunity

Duke University is one of a select group of institutions globally invited to engage in this opportunity.

Resourcing for breakthrough science

Selected research proposals, not typically funded by traditional grant support, will receive up to USD 1M over three years.

A dedicated NIBR Alliance Manager will support the collaboration so that the scientists can focus on the science.

Access to inter-disciplinary expertise and more

Academic scholars will have access to disease area drug-hunting and translational research expertise. By joining forces with our entrepreneurially motivated scientists, they can challenge the status quo, take bold risks, and advance research into early development stages in some cases.

Contributions by NIBR to facilitate collaboration with selected scholars may include data, non-proprietary materials, or services, subject to review and approval.

How it works

Ask the Duke University Office for Translation & Commercialization (OTC) for more information including NIBR’s strategic areas of interest (Challenge Questions) and how to submit your proposal. We have guided multiple applicants through the proposal process and have had a Duke researcher selected for this program.

For more information, please contact Fedor Kossakovski at fdk@duke.edu with the subject line: “NGSP Duke proposal interest”